Transforming Health and Biotech
BioCentriq is revolutionizing cell and gene therapy. Based in Newark, NJ, this startup, founded in 2018, specializes in full-service process development and clinical manufacturing for therapies. Their recent activity highlights a significant milestone with a total raise of $29.2 million, advancing their capabilities in manufacturing various therapies, including cell therapies, gene therapies, immunotherapies, and vaccines.
In Ohio, Clarametyx Biosciences is taking on life-threatening infections. Their focus is on developing biologic therapies targeting biofilms, a protective barrier around bacteria. Founded in 2020, they’ve made strides with a total funding of $33 million, aiming to pioneer treatments in the preclinical stage.
Pioneering Digital Health Solutions
Credo, based in Denver, CO, is a leader in automating patient medical record retrieval. Established in 2021, they’ve raised $5.25 million to innovate healthcare processes. Their digital solution aims to replace outdated fax-based methods, improving patient care by ensuring accurate and complete health records.
San Francisco’s HI-Bio is leading a new chapter in clinical immunology. They focus on therapies targeting cellular drivers of immune-mediated diseases. Since its inception in 2021, HI-Bio has raised an impressive $215 million, showcasing their commitment to precision medicine and innovative therapeutic solutions.
Enhancing Online Safety
Another San Francisco-based startup, Intrinsic, is on a mission to build safer digital platforms. They provide a unified API for safety technologies, enabling cohesive policy-to-enforcement solutions for Trust & Safety teams. Since 2023, they’ve raised $3.1 million and are poised to make significant contributions to online security and safety.
From Connecticut, Koree offers a unique shopping experience. Founded in 2022, this startup has raised $200,000 for its application that rewards shoppers with cashback from their favorite merchants. They’re redefining retail engagement and consumer rewards.
Redefining Drug Delivery
Liquidia Corporation in Morrisville, NC, is transforming drug development with their PRINT® technology. Founded in 2004, they’ve secured $155 million in funding. This biopharmaceutical company’s technology precisely engineers drug particles, offering solutions to common drug delivery challenges and enhancing patient safety and treatment efficacy.